All Stories

  1. The Norfolk Smell and Taste Clinic Experience—A Decade of Olfactory and Gustatory Dysfunction
  2. Smell and Taste Disorder Impact on Eating Habits: A Cross‐Sectional Observational Study
  3. Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management
  4. Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review
  5. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  6. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  7. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  8. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  9. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  10. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  11. The need to promote smell health across the globe
  12. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  13. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  14. The need to promote smell health across the globe
  15. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  16. Gustatory dysfunction in dementia and cognitive decline
  17. Olfactory loss and dysfunction in dementia and cognitive decline
  18. A New Approach to Dementia
  19. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  20. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  21. Epidemiology of Cholesteatoma in the UK Biobank
  22. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  23. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  24. Epidemiology of Cholesteatoma in the UK Biobank
  25. Smell Above All: Envisioning Smell-Centred Future Worlds
  26. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  27. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  28. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  29. Obesity and Olfaction
  30. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  31. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  32. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  33. Delivery of Topical Drugs to the Olfactory Cleft
  34. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  35. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  36. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  37. Position paper on olfactory dysfunction: 2023
  38. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  39. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  40. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  41. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  42. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  43. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  44. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  45. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  46. Nose Gym: An Interactive Smell Training Solution
  47. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  48. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  49. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  50. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  51. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  52. The Nose and the Effects of SARS-CoV-2 Pandemic
  53. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  54. The EUFOREA pocket guide for chronic rhinosinusitis
  55. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  56. Investigations and Outcomes for Olfactory Disorders
  57. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  58. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  59. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  60. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  61. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  62. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  63. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  64. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  65. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  66. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  67. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  68. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  69. International consensus statement on allergy and rhinology: Olfaction
  70. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  71. Interventions for the treatment of persistent post-viral olfactory dysfunction
  72. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  73. Olfaction and CSF Leak
  74. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  75. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  76. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  77. Barriers to effective health care for patients who have smell or taste disorders
  78. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  79. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  80. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  81. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  82. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  83. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  84. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  85. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  86. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  87. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  88. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  89. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  90. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  91. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  92. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  93. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  94. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  95. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  96. Patient Experiences of Postinfectious Olfactory Dysfunction
  97. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  98. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  99. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  100. Comparison of COVID-19 and common cold chemosensory dysfunction
  101. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  102. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  103. Patient Experiences of Post-Infectious Olfactory Dysfunction
  104. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  105. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  106. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  107. Olfactory Loss of Function as a Possible Symptom of COVID-19
  108. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  109. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  110. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  111. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  112. Qualitative Olfactory Disorders: Patient experiences and self-management
  113. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  114. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  115. Parosmia is associated with relevant olfactory recovery after olfactory training
  116. The impact of patients losing their sense of smell
  117. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  118. Cholesteatoma and family history: An international survey
  119. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  120. Biologics for chronic rhinosinusitis
  121. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  122. Biologics for chronic rhinosinusitis
  123. An unmet need: Patients with smell and taste disorders
  124. 139 Risk of parkinson’s in idiopathic anosmia
  125. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  126. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  127. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  128. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  129. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  130. What is the most appropriate treatment for chronic rhinosinusitis?
  131. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  132. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  133. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  134. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  135. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  136. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  137. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  138. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  139. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  140. Wooden spatula sinusitis following maxillary expansion surgery
  141. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  142. Topical and systemic antifungal therapy for chronic rhinosinusitis
  143. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  144. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  145. Saline irrigation for allergic rhinitis
  146. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  147. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  148. Endonasal Approaches to Maxillary Sinus
  149. The use of nasal sprays and rinses in patients with chronic sinus disease
  150. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  151. Initial assessment in the management of adult epistaxis: systematic review
  152. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  153. Health care usage and quality of life reporting in chronic sinusitis patients
  154. The genetics of cholesteatoma. A systematic review using narrative synthesis
  155. Position paper on olfactory dysfunction
  156. Chronic rhinosinusitis and mood disturbance
  157. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  158. Saline irrigation for allergic rhinitis
  159. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  160. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  161. Position paper on olfactory dysfunction
  162. Chronic rhinosinusitis and mood disturbance
  163. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  164. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  165. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  166. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  167. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  168. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  169. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  170. Topical and systemic antifungal therapy for chronic rhinosinusitis
  171. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  172. SNOT-22 in a control population
  173. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  174. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  175. Genetics of Cholesteatoma Project
  176. Short-course oral steroids alone for chronic rhinosinusitis
  177. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  178. Different types of intranasal steroids for chronic rhinosinusitis
  179. Systemic and topical antibiotics for chronic rhinosinusitis
  180. Saline irrigation for chronic rhinosinusitis
  181. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  182. Chronic rhinosinusitis and mood disturbance
  183. Long term quality of life in patients with fungal sinus disease
  184. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  185. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  186. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  187. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  188. Systemic and topical antibiotics for chronic rhinosinusitis
  189. Saline irrigation for chronic rhinosinusitis
  190. Different types of intranasal steroids for chronic rhinosinusitis
  191. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  192. Short-course oral steroids alone for chronic rhinosinusitis
  193. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  194. The impact of commissioning for rhinosinusitis in England
  195. Investigation of nasal diseases
  196. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  197. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  198. Authors’ response
  199. Hyposmia
  200. Assessing the sense of smell
  201. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  202. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  203. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  204. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  205. The Impact of Olfactory Disorders in the United Kingdom
  206. Chronic Rhinosinusitis and Mood Disturbance
  207. Management of CRSwNPs Surgically
  208. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  209. SNOT-22 in a Control Population
  210. Anatomy and Physiology of the Olfactory and Gustatory Systems
  211. Cerebrospinal Fluid Rhinorrhoea
  212. Ciliary Motility Disorders
  213. Clinical Governance and Audit
  214. Complications of Sinusitis
  215. Endoscopic Sinus Surgery and Complications
  216. Epistaxis
  217. European Position Paper on Rhinosinusitis and Nasal Polyps
  218. Facial Flaps, Scars, and Keloids
  219. Facial Fractures and Swelling
  220. Fungal Sinus Disease
  221. Headache and Facial Pain
  222. Medical Statistics
  223. Microbiology of ENT
  224. Olfactory and Gustatory Disorders
  225. Sinonasal Anatomy and Physiology
  226. Tumours of the Nose and Paranasal Sinuses
  227. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  228. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  229. Unilateral cacosmia: a presentation of maxillary fungal infestation
  230. When mealtime is the most dreaded moment of your day
  231. Pneumatisation of turbinates and paranasal sinuses in children: case report
  232. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  233. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  234. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  235. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  236. A useful tool - systematic checklist for evaluating sinus scans
  237. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  238. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  239. Allergic fungal rhinosinusitis - a new staging system
  240. Allergic fungal rhinosinusitis - a new staging system
  241. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  242. Selecting the Best Approach to the Frontal Sinus
  243. Nanomedicine in otorhinolaryngology: what does the future hold?
  244. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  245. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  246. Tumefactive fibroinflammatory lesion of the frontal sinus
  247. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  248. SUBJECTS AND METHODS
  249. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  250. Proximal Lacrimal Obstruction – A Review
  251. The superosmic phenomenon
  252. The Leicester Olfactometer
  253. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  254. ENT cases seen at a local ‘walk-in centre’: a one year review
  255. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  256. A brief history of olfaction and olfactometry
  257. The superosmic phenomenon
  258. Olfactory clearance: what time is needed in clinical practice?
  259. The Effect of Female Hormone Manipulation on Nasal Physiology
  260. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  261. R152: Olfactory Adaptation and Clearance in Clinical Practice
  262. Bronchiectasis and sino-nasal disease: a review
  263. What is the short term effect of perfumes on olfactory thresholds?
  264. Which variables matter in smell tests in the clinic?
  265. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  266. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  267. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  268. Comparison of Subjective Perception with Objective Measurement of Olfaction
  269. Response to Rachmanidou
  270. A double‐blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on postoperative symptoms
  271. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  272. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  273. Do our Noses Lead Us Away from the Scent?
  274. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  275. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  276. Is there a role for more day-case septal surgery?
  277. Erratum
  278. Canalicular adenoma of the parotid gland
  279. Paediatric retropharyngeal abscess
  280. Which solvent for olfactory testing?
  281. Nasal physiological changes during pregnancy
  282. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  283. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  284. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  285. Subjects and methods
  286. Hyposmia